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Abstract
Background: Hippo, a Drosophila serine/threonine kinase, promotes apoptosis and restricts cell growth and proliferation. Its
mammalian homolog MST2 has been shown to play similar role and be regulated by Raf-1 via a kinase-independent
mechanism and by RASSF family proteins through forming complex with MST2. However, regulation of MST2 by cell survival
signal remains largely unknown.
Methodology/Principal Findings: Using immunoblotting, in vitro kinase and in vivo labeling assays, we show that IGF1
inhibits MST2 cleavage and activation induced by DNA damage through the phosphatidylinosotol 3-kinase (PI3K)/Akt
pathway. Akt phosphorylates a highly conserved threonine-117 residue of MST2 in vitro and in vivo, which leads to
inhibition of MST2 cleavage, nuclear translocation, autophosphorylation-Thr180 and kinase activity. As a result, MST2
proapoptotic and growth arrest function was significantly reduced. Further, inverse correlation between pMST2-T117/pAkt
and pMST2-T180 was observed in human breast tumors.
Conclusions/Significance: Our findings demonstrate for the first time that extracellular cell survival signal IGF1 regulates
MST2 and that Akt is a key upstream regulator of MST2.
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Introduction
MST2 and its close homologue MST1 are members of the
germinal center kinase group II (GCK II) family of mitogen-
activated protein kinase (MAPK)–related kinases that includes the
more distantly related kinases MST3, MST4, LOK, SOK, and
SLK. Unlike other members, MST1 and MST2 contain a Ste20-
related kinase catalytic domain in the N-terminal region followed
by a noncatalytic tail that contains an autoinhibitory domain, a
dimerization domain, and two nuclear export sequences at the
COOH terminus [1,2,3]. It has been shown that the noncatalytic
tail is cleaved by caspase upon various apoptotic stimuli [4,5,6].
Ectopic expression of MST1/2 induces striking morphological
changes characteristic of apoptosis in both nucleus and cytoplasm.
During the execution phase of apoptosis in mammalian cells
induced by proapoptotic stimuli, MST1 and MST2 are activated
by caspase cleavage and subsequently translocated to the nucleus.
In the case of MST1, this leads to a constitutive phosphorylation of
H2B, resulting in nuclear DNA fragmentation [7]. It has been
shown that the protective function of the Raf1 (including kinase-
dead Raf-1) against apoptosis involves the inhibition of MST2
activity by direct sequestration and inhibition of MST2 activation
[8,9]. In addition, RASSF (Ras association domain family)
proteins RASSF1A and RASSF5 have been demonstrated to
bind MST1 [10,11,12]. RASSF1A also releases MST2 from the
inhibitory effect of Raf-1[13]. RASSF1A also releases MST2 from
the inhibitory effect of Raf-1 [13]. Ultimately, RASSF1A and
RASSF5 activate NDR1, NDR2, and LATS1 to induce apoptosis
[13,14,15,16]. These findings suggest that RASSF1A and RASSF5
stimulate MST signaling. A recent study shows that RASSF6
interacts with MST2 and inhibits MST2 activity. However,
RASSF6 caused apoptosis when released from activated MST2 in
a manner dependent on WW45 [17]. These findings suggest that
activation of MST2 causes apoptosis through the canonical
pathway, as well as through a RASSF6-mediated pathway [17].
In Drosophila, Hippo, a homolog of mammalian MST2, restricts
cell growth and cell proliferation and promotes cell death by
interaction with the tumor suppressors Salvador (Sav)/WW45 and
Warts (Wts)/Lats1/Lats2, which result in inhibition of transcrip-
tion and/or degradation of cyclin E and DIAPs [18,19], through
phosphorylation of Yorkie, which is the Drosophila ortholog of the
mammalian transcription co-activator yes-associated protein
(YAP) [20]. YAP and Yorkie have recently been shown to be
negatively regulated by the Hippo/MST pathway and play an
important role in mediating cell contact inhibition, organ size and
tumorigenesis [21,22].
Accumulated evidence shows that Akt and its downstream
targets constitute a major cell survival pathway. Akt inhibits
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by a variety of stimuli through regulation of down stream
molecules [23,24]. Akt phosphorylates BAD on serine 136,
which promotes the association of BAD a pro-apoptotic
protein in Bcl-2 family, with 14-3-3 proteins in the cytosol,
thus inactivating its pro-apoptotic function [25]. In addition,
Akt reduces the transcription of a subset of pro-apoptotic genes
by phosphorylation of Forkhead transcription factors, which
causes their nuclear exclusion and inactivation [26], including
FOXO1, FOXO3a, and FOXO4 and the phosphorylation by
Akt negatively regulates FOXO activity by relocalizing FOXO
from nucleus to the cytoplasm, where it is sequestered away
from target genes through interacting with 14-3-3 [27]. In
addition, several pro-apoptotic and anti-apoptotic proteins are
also phosphorylated by Akt, including ASK1 [28], XAIP [24],
Par-4 [29], BAX [30,31], HtrA2 [32], which leads to direct
activation of cell survival pathway.
A previous study showed that EGF stimulation caused a drop
of MST1 kinase activity [33]. However, the regulation of
MST2/Hippo by cell survival signaling remains largely
unknown. In this report, we demonstrate that MST2 is inhibited
by IGF1 through the PI3K/Akt pathway. Akt phosphorylates
MST2 at Thr117 in vitro and in vivo, which leads to inhibition of
MST2 cleavage and kinase activity as well as nuclear
translocation. Furthermore, Akt activation is inversely correlat-
ed with autophosphorylation of MST2-T180 but paralleled with
MST2-T117 phosphorylation in breast tumors. Collectively, our
findings suggest that MST2 is a bona fide substrate of Akt and
that Akt could play a critical role in regulation of the Hippo/
MST2 pathway.
Materials and Methods
Reagents, Cell Culture and Breast Tumor Specimens
Stauroporine, LY294002 were obtained from Sigma (St.
Louis, MO). DMEM and fetal bovine serum were purchased
from Invitrogen Co. (Grand Island, NY). Anti-MST2 (#3952),
-pMST2-Thr180 (#3681), -Akt (#9272), -pAkt-Ser473 (#9271),
-actin (#4967) and -cleaved PARP (#9541 and #9544) antibodies
were from the Cell Signaling Technology (Beverly, MA). Anti-
GFP antibody was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). COS7 and human embryonic kidney (HEK)
293 cells were purchased from The American Type Culture
Collection (ATCC; Manassas, VA) and cultured at 37uC and 5%
CO2 in DMEM supplemented with 10% fetal bovine serum.
Eighty primary human breast cancer specimens were obtained
from patients who underwent surgery at H. Lee Moffitt Cancer
Center and approved by Institutional Review Board. Each sample
contains at least 80% tumor cells, confirmed by microscopic
examination.
Expression Constructs
Flag-tagged MST2 was created by PCR amplification of human
Fetal Marathon-Ready cDNA (Clontech). The PCR products
were cloned to p3XFLAG-CMV-10 vector (Sigma) at EcoRI-
BamHI sites. MST2 specific primers are: ccggaattcatggagcag-
ccgccggcg (59primer), and cgcggatccaaagttttgctgccttct (39primer).
Flag-MST2-T117A and Flag-MST2-T117D were produced with
mutagenesis kit (Stratagene) using wild-type MST2 as template.
Wild type MST2 and mutant MST2 were also cloned to pEGFP-
C1 (Clontech) at EcoRI-BamHI sites. GST-MST2 and GST-
MST2-T117A were created by PCR amplification of 150
nucleotide fragment (a.a. 100–150) which include T117 and
T117A sites using Flag-MST2-T117A and Flag-MST2-T117D as
templates. The fragments were cloned to pGEX-4.1 vector at
BamHI-EcoRI sites. The MST2 plasmids were confirmed by DNA
sequencing. Akt expression constructs were previously described
[32].
Immunoprecipitation, Immunoblotting and In Vitro
Kinase Assay
Immunoprecipitation and immunoblotting were performed
as previously described [24]. The immunoprecipitates were
subjected to Western blotting analysis or in vitro kinase assay.
Protein kinase assays were performed as previously described
[34]. Briefly, reactions were carried out in the presence of
10 mCi of [c-32P] ATP and 3 mM cold ATP in 30 ml buffer
containing 20 mM Hepes (pH 7.4), 10 mM MgCl2,1 0 m M
MnCl2, and 1 mM dithiothreitol using myelin basic protein
(MBP) as substrate. After incubation at room temperature for 30
min the reaction was stopped by adding protein loading buffer
and proteins were separated on SDS-PAGE gels. Each
experiment was repeated three times and the relative amounts
of incorporated radioactivity were determined by autoradiog-
raphy and quantified with a Phosphoimager (Molecular
Dynamics).
In Vivo [
32P] Pi Labeling
COS7 cells were co-transfected with kinase-dead Flag-MST2
and constitutively active Akt. Following 48 h incubation, cells were
labeled with [
32P] Pi (0.5 mCi/ml) in phosphate- and serum-free
DMEM medium for 4 h and then lysed. Cell lysates were
subjected to immunoprecipitation with anti-Flag antibody. The
immunoprecipitates were separated by 7.5% SDS-PAGE and
transferred to membranes. The phosphorylated MST2 band was
visualized by autoradiography.
Cell Death Assay, TUNEL Assay, Caspase3/7 Assay
Cells were seeded into 60-mm dishes and grown in DMEM
supplemented with 10% FBS for 24h, treated with STS (30 mM).
Apoptosis was determined by Tunel assay using an in situ cell
death detection kit (Boehringer Mannheim, Indianapolis, IN) and
caspase 3/7 assay kit (Promega). These experiments were
performed three times in triplicate.
Results
IGF1 Inhibits MST2 through the PI3K/Akt Pathway and
Akt Regulates MST2 Activation
Since MST2 is cleaved and activated upon apoptotic stimuli
and is required for DNA damage-induced apoptosis in different
types of cells, we initially examined if extracellular cell survival
signal regulates MST2 cleavage and activation. COS7 cells
were treated with staurosporine (STS; 1 mM) together with and
without IGF1 for 2 h. Consistent with previous studies, STS
alone induces MST2 cleavage and autophosphorylation of
Thr180, an indicator of MST2 activation, as well as apoptosis.
However, addition of IGF1 largely reduced STS effect
towards MST2. PI3K inhibitor LY294002 inhibited the IGF1
action (Figure 1a). Further, LY294002 and Akt inhibitor API-2
[35] were able to induce MST2 activation and cleavage,
which is inhibited by pan-caspase inhibitor Z-VAD (Figure 1b).
These results imply that STS-induced MST2 cleavage and
activation are inhibited by IGF1 through the PI3K/Akt
pathway.
We next examined the effect of Akt on MST2 activation.
Akt-knockout MEFs were infected with adenovirus expressing
IGF1/Akt Regulates MST2
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low concentration (0.2 mM) considerably induces MST2
activation and cleavage as well as apoptosis in Akt-null MEF
but not Akt-reconstituted cells (Figure 1c). Moreover, knock-
down of Akt1 induces MST2 activation and enhances
doxorubicin-activated MST2 and apoptosis in PTEN-mutated
MDA-MB-468 cells (Figure 1d). Further, ectopic expression of
dominant-negative Akt induces whereas constitutively active
Akt represses MST2-Thr180 autophosphorylation in COS7
cells (Figure 1e). Constitutively active Akt also inhibited the
apoptosis induced by ectopic expression of MST2 in MCF10A
cells (Figure S1). In vitro MST2 kinase activity was also inhibited
by ectopic expression of wild-type and constitutively active Akt
(Figure 1f).
Akt Interacts with and Phosphorylates MST2
We next investigated whether Akt forms a complex with
MST2. COS7 cells were co-transfected with HA-Akt and Flag-
MST2. Co-immunoprecipitation experiments revealed that
Flag-MST2 was readily detected in HA-Akt immunoprecipitates
and vice versa (Figure 2a). Having demonstrated constitutively
active Akt inhibition of MST2 but dominant-negative Akt
activation of MST2 (Figure 1), we reasoned Akt regulation of
MST2 through a kinase-dependent mechanism. Sequence
analysis shows a well-conserved Akt phosphorylation consensus
motif (
112RLRNKT
117) in a kinase domain of MST2 (Figure 2b).
In vivo [
32P]orthophosphate labeling and immunoblotting
analysis with Akt substrate antibody revealed that constitutively
active Akt induced MST2 phosphorylation (Figures 2c and 2d).
Further, we created wild-type and T117A GST-MST2 (a.a.
100–150) fusion proteins which were used as substrate for in vitro
Akt kinase assay. Figure 2e shows that Akt phosphorylates wild-
type but not T117A MST2. These data suggest that MST2 is an
Akt substrate.
Akt Phosphorylates MST2-T117 In Vivo and the pMST2-
T117 Inhibits Thr180 Autophosphorylation
To demonstrate in vivo phosphorylation of MST2-T117 by
Akt, we generated specific phospho-MST2-T117 antibody by
immunization of a rabbit with phospho-peptides (Ac-
IRLRNK(pT)LIEDEIA-amide). We first characterized the
specificity of this antibody. HEK293 cells were co-transfected
with constitutively active HA-Akt and full-length wild-type and
T117A mutant Flag-MST2. After immunoprecipitation
with anti-Flag antibody, immunoblotting analysis with anti-
pMST2-T117 antibody revealed that Akt phosphorylates wild-
type but not T117A mutant MST2 (Figure 3a). We further
showed that ectopic expression of wild-type or constitutively
active Akt induced MST2-T117 phosphorylation whereas
dominant negative Akt decreased the phosphorylation com-
pared to that of the cells transfected with vector alone
(Figure 3b).
In addition, serum starvation reduces whereas IGF1 induces
pMST2-T117 levels (Figure 3c). Introduction of Akt into Akt-null
MEFs also increases pMST2-T117 (Figure 3d). Notably, pMST2-
T117 is inversely correlated with autophosphorylation of Thr180
(Figures 3c and 3d). We also observed that knockdown of Akt in
MDA-MB-468 cells reduced pMST2-T117 but increased
pMST2-T180 (Figure 3e). Based on these findings, we hypoth-
esized that Akt phosphorylation of Thr117 is required for
inhibition of autophosphorylation of Thr180 of MST2. To test
this, we introduced Akt phosphomimetic Flag-MST2-T117D and
nonphosphorylatable Flag-MST2-T117A as well as wild-type
Flag-MST2 into HEK293 cells. After immunoprecipitation with
Flag antibody, immunoblotting analysis revealed that antopho-
sphorylation of MST2-T180 was detected in the cells transfected
with MST2-T117A and MST2 but not with MST2-T117D
(Figure 3f). Collectively, we conclude that MST2 is bona fide
substrate of Akt and the phosphorylation of Thr117 negatively
regulates pMST2-T180.
Akt Inhibits MST2 Nuclear Translocation, Cleavage and
Kinase Activity via a pThr117-Dependent Mechanism
Because the MST2 cleavage and nuclear translocation are
critical steps for MST2 function and because Akt phosphory-
lates MST2-T117, we reasoned that Akt could inhibit MST2
nuclear translocation and that this action could depend on
phosphorylation of Thr117. To this end, we created GFP-
tagged wild-type MST2, Akt phosphomimetic MST2-T117D
and nonphosphorylatable MST2-T117A. After transfection of
COS7 cells with the various forms of GFP-MST2 together with
and without constitutively active Akt, subcellular localization of
GFP-MST2 was examined under a fluorescence microscope.
Figure 4a shows that STS treatment induces WT-MST2 nuclear
translocation which was inhibited by constitutively active Akt.
Under non-DNA damage (e.g., STS) condition, constitutively
active Akt also reduced approximately half of ectopically
expressed wild-type MST2 nuclear translocation (Figure 4b).
MST2-T117A exhibited nuclear localization whereas MST2-
T117D located at cytoplasm. Expression of constitutively active
Akt had no effect on subcellular localization of MST2-T117A
and MST2-T117D (Figure 4b).
Having demonstrated Akt inhibition of MST2 nuclear
translocation through phosphorylation of Thr117, we next
examined if Akt inhibition of MST2 cleavage and kinase
activity depends on phosphorylation of Thr117. After trans-
fection with Flag-tagged wild-type and mutant MST2 together
with and without constitutively active Akt, COS7 cells were
Figure 1. IGF1/PI3K/Akt inhibits MST2 cleavage, activation and MST2-induced cell death. (a) IGF1 inhibits MST2 through the PI3K/
Akt pathway. Top panel is domain structure of MST2. DELD is a caspase cleavage motif and NES stands for nuclear export signal. Middle panels
are immunoblots of COS7 cells, which were treated with IGF1 (50 mM) or/and LY294002 (20 mM) for 30 min prior to exposure to STS (1 mM) for
1 h, with indicated antibodies. Bottom panel shows the apoptosis measured with Tunel assay in three experiments in triplicate. (b) Inhibitors of
PI3K (LY294002) and Akt (API-2) activate MST2. After treatment with indicated compounds for 3 h, COS7 cells were subjected to
immunoblotting with indicated antibodies (upper panels) and apoptosis analysis (bottom). (c) Reconstitution of Akt in Akt1-null MEFs reduces
MST2 activation induced by STS. Akt1-knockout MEFs were infected with adenovirus expressing Akt and then treated with 0.2 mMS T Sf o r1 h .
Immunoblotting (upper) and apoptosis (bottom) analyses were performed as described above. (d) Knockdown of Akt enhances doxorubicin-
activated MST2. MDA-MB-468 cells were transfected/treated with Akt/shRNA together with or without doxorubicin, and then subjected to
immunoblotting (upper) and Tunel (bottom) analyses. (e) and (f) Constitutively active (Ac) Akt inhibits but dominant-negative (DN) Akt induces
MST2 activation. COS7 cells were transfected with indicated plasmids. Following 48 h of incubation, cells were assayed for autophospho-T180
(top panel of e) and in vitro MST2 kinase using MBP as substrate (top panel of f). Middle and bottom panels show expression of the transfected
plasmids.
doi:10.1371/journal.pone.0009616.g001
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that STS treatment induced the cleavage of MST2-T117A and
wild type MST2, but had no significant effect on the cleavage
of MST2-T117D (Figure 4c). Moreover, ectopic expression of
constitutively active Akt reduced STS-stimulated wild-type
MST2 but not MST2-T117A cleavage (Figure 4d). We have
also examined whether the Akt phosphorylation of thr-117
affects MST2 kinase activity. In vitro kinase assays revealed
Figure 2. Akt interacts with and phosphorylates MST2. (a) MST2 binds to Akt. COS7 cells were co-transfected with Flag-MST2 and
HA-Akt. After 48 h of transfection, cells were lysed, immunoprecipitated with anti-Flag and detected with HA antibody (top) and vice
versa (bottom). (b) Sequence alignment shows a highly conserved Akt phosphorylation consensus site of MST2 among different species. (c)
and (d) Akt phosphorylates MST2 in vivo. COS7 cells were transfected with kinase-dead Flag-MST2 together with or without constitutively
active (Ac) dominant-negative (DN) Akt. Following 36 h of transfection, cells were either labeled by [
32P]-orthophosphate (c) or
immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Akt-substrate antibody (top panel of d). For in vivo labeled cells,
immunoprecipitation was performed with anti-Flag antibody and exposed to a film (top panel of c). Middle and bottom panels show
expression of the transfected plasmids. (e) Akt phosphorylates MST2-T117 in vitro. In vitro Akt kinase assay was carried out by incubation of
recombinant active Akt and GST-WT-MST2 and -MST2-T117A fused proteins (top). Bottom panel is coomassie blue staining of GST-MST2
proteins.
doi:10.1371/journal.pone.0009616.g002
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PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9616Figure 3. Akt phosphorylates Thr117 of MST2 in vivo and the pMST2-T117 regulates autophospho-MST2-T180. (a) Characterization of
anti-pMST-T117 antibody. HEK293 cells were transfected with constitutively active Akt and Flag-MST2 or Flag-MST2-T117A and immunoprecipitated
with anti-Flag antibody. The immunoprecipitates were immunoblotted with anti-pMST2-T117 antibody (top). Middle and bottom panels show
expression of the transfected plasmids. (b) Akt phosphorylates endogenous MST2-T117. Following transfection of HEK293 cells with indicated different
Akt, cells were lysed and immunoblotted with anti-pMST2-T117 (top), -MST2 (panel 2), -HA (panel 3) and -actin (bottom) antibodies. (c) IGF1 induces
pMST2-T117 and represses pMST2-T180. After serum starvation for 12 h, HEK293 cells were stimulated with IGF1 for 1 h and then immunoblotted with
indicated antibodies. (d) Re-expression of Akt in Akt1
-/- MEF increases pMST2-T117 and reduces pMST2-T180 level. Akt1-null MEFs were infected with
adenovirus expressing Akt or control vector and immunoblotted with indicated antibodies. (e) Knockdown of Akt decreases pMST2-T117 and increases
pMST2-T180. MDA-MB-468 cells were transfected with AKT1/shRNA and control shRNA. After 72 h incubation, cells were lysed and immunoblotted with
indicated antibodies. (f) Phospho-Thr117 regulates MST2 autophosphorylation of Thr180. HEK293 cells were transfected with indicated plasmids and
immunoprecipitated with anti-Flag antibody. The immunoprecipitates were immunoblotted with anti-pMST2-T180 (top) and -Flag (bottom) antibodies.
doi:10.1371/journal.pone.0009616.g003
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phosphomimetic MST2-T117D whereas nonphosphoryla-
table MST2-T117A exhibited much higher kinase activity
compared to wild type MST2 in the absence or presence of
STS (Figure 4c). In combination of the findings in Figure 2b,
these data indicate that full-length MST2-T117A is able to
translocate to the nucleus and exhibits high level of kinase
activity whereas MST2-T117D remains in cytoplasm and loses
its kinase activity. Further, Akt had no effect on MST2-T117A
kinase activity (Figure 4d). Taken collectively, these results
indicate that phosphorylation of Thr117 is required for Akt
inhibition of MST2 cleavage, nuclear translocation and kinase
activity.
Phosphorylation of Thr117 Reduces MST2-Induced
Apoptosis and Growth Arrest and Is Associated with pAkt
in Breast Cancer
We next examined the effects of phosphorylation Thr117 on
MST2-regulated cell survival and growth. Figure 5a shows that
ectopic expression of MST2 and MST2-T117A in HEK293
cells induced PARP cleavage whereas MST2-T117D had no
effect on PARP cleavage compared to the cell transfected with
vector alone. Caspase-3/7 activity was also increased by
expression of MST2 and MST2-T117A but not MST2-
T117D. Moreover, constitutively active Akt reduced the effect
of wild-type MST2 but had no influence on MST2-T117A and
MST2-T117D (Figure 5b). Previous studies have also shown
that MST2 activation inhibits cell proliferation [36]. Thus, we
have performed cell proliferation assay and observed that cell
growth was significantly decreased in MST2-T117A cells
whereas increased in MTS2-T117D cells when compared to
wild-type-MST2 and vector-transfected cells (Figure 5c).
Because Akt phosphorylation of MST2-T117 inhibits autopho-
spho-MST2-T180 (Figures 2 and 3), we also investigated
whether this regulation also existed in tumor tissues. Western
blot analysis was performed in 80 human primary breast
carcinomas. Elevated levels of phospho-Akt were detected in
40 specimens (Figure 5d and data not shown), 33 of which
exhibited high levels of phospho-MST2-T117 whereas 35 of
which express low or undetectable level of phospho-MST2-
T180. Notably, all 33 tumors with high levels of phospho-Akt/
phospho-MST2-T117 had low phospho-MST2-T180. Statistic
analysis revealed that phospho-Akt significantly links to
phospho-MST2-T117 (p,0.0001) which inversely correlates
with phospho-MST2-T180 (p,0.0001; Figure 5e). In addition,
overall survival of the patients with elevated pMST2-T117/
low pMST2-T180 is significantly lower than those with low
pMST2-T117/high p-MST1-T180 (Figure 5f). Taken togeth-
e r ,w ec o n c l u d et h a tM S T 2i sabona fide substrate of Akt and
that pMST2-T117 could be a prognostic marker in human
breast cancer.
Discussion
MST1 and MST2 are human homologes of Hippo, however,
protein sequence similarity between MST2 and Hippo (63.5%) is
higher than that of MST1 versus Hippo (50%). Previous studies
have shown that Hippo/MST is autophosphorylated and cleaved
by caspases in response to apoptotic stimuli. The cleaved N-
terminal kinase domain (e.g., activated MST2) subsequently
translocates into the nucleus where it interacts and phosphorylates
tumor suppressors Salvador (WW45) and Warts (Lats1/2), which
result in inhibition of transcription and/or degradation of DIAPs
and cyclin E leading to apoptosis and cell growth arrest [18,19,37].
In this study, we demonstrate that IGF1 inhibits MST2 cleavage
and activation through the PI3K/Akt pathway. Small molecule
inhibitors of PI3K/Akt or depletion of Akt activate MST2.
Further, Akt interacts with MST2 and phosphorylates MST2-
T117 in vitro and in vivo leading to inhibition of MST2 cleavage,
autophosphorylation and kinase activity. The phosphorylation of
Thr117 abrogates MST2 proapoptotic and cell growth-inhibitory
function. These results indicate Akt as a key upstream regulator of
MST2 and provide a mechanism by which Akt promotes cell
survival through direct phosphorylation of MST2 at Thr117
(Figure 6).
A previous study has demonstrated that Raf-1 kinase binds to
MST2 and prevents its dimerization and autophosphorylation
of Thr180, which results in inhibition of MST2 activation and
proapoptotic activity [8]. Intriguingly, this regulation is
independently of Raf-1 protein kinase activity because kinase-
n e g a t i v eR a f - 1a l s oc o u l di n h i b i tM S T 2a c t i v a t i o na n da p o p t o s i s
[8]. While Akt interacts with MST2, the regulation of MST2 by
Akt depends on its kinase activity since constitutively active Akt
inhibits whereas dominant-negative Akt induces MST2 activa-
tion (Figures 1 and 4). In addition, Akt mediates IGF1 signal
towards MST2 and directly phosphorylates Thr117. The
phosphorylation of Thr117 is required for Akt inhibition of
MST2. Thus, our findings provide the evidence that IGF1/Akt
survival signal regulates MST2 through a phosphorylation of
Thr117-dependent mechanism.
Our study shows that MST2 possesses an Akt phosphory-
lation site (
112RLRNKT
117) within its N-terminal kinase
domain (Figure 1a), which is highly conserved among yeast,
Drosophila, Xenopus, mouse, and human. Moreover, this motif
also exists in MST1 (Figure 2b). The Hippo pathway was
initially identified in the fly to control organ size. Its core
components are evolutionally conserved in mammals. Hippo,
Sav, Wts and Mats in the fly are homologous to mammalian
MST1/2, WW45, LATS1/2, and Mob1, respectively [38].
Previous studies also showed that the Drosophila insulin receptor
transduces signals that positively regulate cell and organ
growth through its downstream molecule Chico/Dp110/
Dakt1 [39,40]. Overexpression of the Dakt1 dramatically
increases clonal size in wing imaginal disc through an
Figure 4. Akt phosphorylation of Thr117 reduces MST2 nuclear translocation and activation. (a) and (b), Akt inhibits wild-type MST2
nuclear translocation but has no effects on MST2-T117A and MST2-T117D. Panel (a) shows that STS-induced MST2 nuclear translocation was
inhibited by Akt. COS7 cells were transfected with GFP-MST2 together with and without constitutively active Akt. After STS treatment for 2 h,
cellular distribution of MST2 was examined (top) and quantified (bottom) under fluorescent microscopy. In panel b, COS7 cells were transfected
with different forms of GFP-MST2 together with and without constitutively active Akt. After 36 h incubation, cells were examined and quantified
for the nuclear MST2. The experiments were repeated for three times and 200 cells/transfection were examined. (c) Phospho-Thr117 reduces
MST2 cleavage and kinase activity. COS7 cells were transfected with indicated plasmids. Following treatment with and without STS, cells were
subjected to immunoblotting (top) and immunoprecipitation with anti-Flag antibody. The immunoprecipitates were subjected to in vitro MST2
kinase assay using MBP as substrate (bottom). (d) Akt failed to inhibit STS-induced MST2-T117A cleavage and kinase activity. COS7 cells were
transfected/treated with indicated plasmids and reagent and then subjected to Western blot (top) and in vitro MST2 kinase assay (bottom) as
described above.
doi:10.1371/journal.pone.0009616.g004
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PLoS ONE | www.plosone.org 8 March 2010 | Volume 5 | Issue 3 | e9616Figure 5. Akt inhibition of MST2 cellular function depends on the phosphorylation of Thr117. (a) MST2-T117A increases PARP
cleavage. HEK293 cells were transfected with indicated plasmids and then immunoblotted with indicated antibodies. (b) Akt inhibits WT-
MST2 but not MST2-T117A-induced apoptosis. HEK293 cells were transfected with indicated plasmids. After 36 h of transfection, caspase3/7
activity was measured. The experiment was repeated three times in triplicate. (c) Cell growth curve. Indicated plasmids were introduced into
HEK293 cells. Cell number was accounted daily for three days. MST2-T117A significantly inhibited whereas MST2-T117D increased cell growth
compared to cells transfected with MST2 or vector alone. (d) Representative breast cancer specimens were lysed and immunoblotted with
indicated antibodies. (e) Inverse expression of pMST2-117/Akt-S473 and pMST2-T180 was detected in majority of human breast tumors.
(f) Overall survival (OS) in patients with high pMST2-T117/low pMST2-T180 (n=32) versus low pMST2-T117/high pMST2-T180 patients (n=29)
was plotted by the Kaplan-Meier method. Statistical comparison of survival between groups with the log-rank statistic analysis suggests that
patients whose tumors express pMST2-T117 (+)/pMST2-T180 (2) had poor survival compared to those with pMST2-T117 (2)/pMST2-T180 (+)
(P=0.01).
doi:10.1371/journal.pone.0009616.g005
IGF1/Akt Regulates MST2
PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9616enlargement of the cells [39]. These studies suggest that the
crosstalk between Akt and Hippo/MST regulates cell growth
and survival and that Akt phosphorylation of MTS2-T117
represents a major regulatory mechanism of the MST2/Hippo
pathway among different species.
A previous study showed that Akt phosphorylates Thr387 at C-
terminal region of MST1 to abrogate MST1 function [41].
However, Thr387 is not conserved in MST2 and Hippo. As
described above, Thr117 of MST2 is conserved in MST1
(Figure 2b). Thus, Akt could regulate both MST1 and MST2
through phosphorylation of the same (e.g., Thr117/Thr120) and
different (e.g., Thr387) sites. In addition, it has been shown that
full-length and cleaved forms of MST1 and MST2 bind to C-
terminal hydrophobic region of Akt and inhibit Akt activation (42),
suggesting a negative feedback regulation loop between Akt and
MST1/MST2 (Fig. 6). Further investigations are required to
define the physiological importance of these Akt phosphorylation
sites and feedback regulation between of Akt-MST in knock-in
mouse model.
Supporting Information
Figure S1 MST2-induced apoptosis is inhibited by constitutively
active Akt. MCF10A cells were transfected with Flag-MST2 and
constitutively active HA-myr-Akt. After 36 h of incubation, cells
were subjected to Tunel assay (A) and immunoblotting with
indicated antibodies (B).
Found at: doi:10.1371/journal.pone.0009616.s001 (2.13 MB TIF)
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